IMMUNOVANT INC (IMVT) Stock Analyst Earnings Estimates
NASDAQ:IMVT - Nasdaq - US45258J1025 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A 590.48% | N/A 470.30% | N/A 186.77% | N/A 108.56% | N/A 64.47% | N/A 29.46% | |||||||
| EBITDA YoY % growth | N/A | -66.06M | -108.05M -63.56% | -155.9M -44.29% | -208.09M -33.48% | -269.978M -29.74% | N/A -73.76% | N/A -6.33% | N/A -18.80% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -66.08M | -108.12M -63.62% | -156.03M -44.31% | -208.28M -33.49% | -270.209M -29.73% | N/A -71.44% | N/A -16.80% | N/A -7.80% | N/A 23.05% | N/A 101.21% | N/A 17,243.69% | N/A 124.60% | N/A 37.68% | ||
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | -1.33 | -1.24 6.77% | -1.43 -15.32% | -1.71 -19.58% | -1.90 -11.11% | N/A -53.17% | N/A -7.39% | N/A -1.25% | N/A 32.50% | N/A 79.66% | N/A 1,099.53% | N/A 226.44% | N/A 40.17% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.76 -112.03% | -0.78 -49.26% | -0.85 -41.10% | -0.90 -21.64% | -0.90 -18.26% | -0.91 -16.97% |
| Revenue Q2Q % growth | ||||||
| EBITDA Q2Q % growth | -123.268M -100.81% | -128M -58.71% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -121.579M -97.52% | -126.27M -56.12% | -134.532M -42.69% | -141.415M -22.18% | -142.634M -17.32% | -141.971M -12.43% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.74 -64.44% | -0.61 | -0.13 | -21.51% |
| Q1 2025 Q2Q % growth | -0.60 -5.26% | -0.54 | -0.06 | -11.53% |
| Q4 2024 Q2Q % growth | -0.52 -13.04% | -0.44 | -0.08 | -19.49% |
| Q3 2024 Q2Q % growth | -0.36 26.53% | -0.44 | 0.08 | 18.17% |
| Q2 2024 Q2Q % growth | -0.45 -9.76% | -0.48 | 0.03 | 6.25% |
| Q1 2024 Q2Q % growth | -0.57 -62.86% | -0.46 | -0.11 | -25.20% |
| Q4 2023 Q2Q % growth | -0.46 -12.20% | -0.44 | -0.02 | -5.41% |
| Q3 2023 Q2Q % growth | -0.49 -36.11% | -0.40 | -0.09 | -23.63% |
| Q2 2023 Q2Q % growth | -0.41 -17.14% | -0.40 | -0.01 | -2.74% |
| Q1 2023 Q2Q % growth | -0.35 -12.90% | -0.40 | 0.05 | 13.29% |
| Q4 2022 Q2Q % growth | -0.41 -41.38% | -0.38 | -0.03 | -6.99% |
| Q3 2022 Q2Q % growth | -0.36 -12.50% | -0.33 | -0.03 | -7.77% |
| Q2 2022 Q2Q % growth | -0.35 -40.00% | -0.29 | -0.06 | -22.55% |
| Q1 2022 Q2Q % growth | -0.31 18.42% | -0.32 | 0.01 | 1.96% |
| Q4 2021 Q2Q % growth | -0.29 23.68% | -0.34 | 0.05 | 14.58% |
| Q3 2021 Q2Q % growth | -0.32 -28.00% | -0.26 | -0.06 | -21.70% |
| Q2 2021 Q2Q % growth | -0.25 34.21% | -0.35 | 0.10 | 27.91% |
| Q1 2021 Q2Q % growth | -0.38 | -0.33 | -0.05 | -13.58% |
| Q4 2020 Q2Q % growth | -0.38 | -0.42 | 0.04 | 9.50% |
| Q3 2020 Q2Q % growth | -0.25 | -0.26 | 0.01 | 3.88% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -2.81% | -34.23% | -0.85% | -17.37% |
| Revenue | N/A | N/A | N/A | N/A |